SusanChoy

Associate

New York + 1.212.326.7835

Collegati

Condividi

Susan Choy represents issuers, financial institutions, and investors in connection with public and private securities offerings, venture capital financings, and cross-border mergers and acquisitions.

Susan has experience representing companies across all growth stages, from initial formation to large public companies. She works with companies in a variety of industries, including SaaS (software as a service), BNPL (buy now, pay later), social media, cryptocurrency, renewable energy, banking, e-commerce, financial technology, health care, life sciences, education, and consumer products.

Esperienze

  • Omnicom Group completes $600 million public offering of Senior NotesJones Day represented Omnicom Group Inc., a leading provider of data-inspired, creative marketing and sales solutions, in connection with its public offering of $600 million of 5.300% Senior Notes due 2034.
  • Kokusai Electric Corporation completes ¥138.2 billion international secondary offeringJones Day represented KSP Kokusai Investments, LLC, a subsidiary of Koch Industries, Inc., as a selling stockholder of 13,319,500 shares of Common Stock, in connection with Kokusai Electric Corporation's international secondary offering of an aggregate of 30,190,800 shares of Common Stock outside of Japan pursuant to Rule 144A/Regulation S.
  • Cibus completes $13 million registered direct offeringJones Day represented Cibus, Inc. in connection with its registered direct offering of 1,298,040 shares of its Class A Common Stock and accompanying Common Warrants to purchase an aggregate of 1,298,040 shares of its Class A Common Stock for an aggregate purchase price of approximately $13 million.
  • Monster Beverage completes $3 billion modified Dutch auction tender offer and secures $1.5 billion credit facilityJones Day represented Monster Beverage Corporation, a leading global drinks manufacturer, in connection with a modified Dutch auction tender offer to purchase up to $3 billion of shares of its Common Stock, as well as the negotiation of a $1.5 billion credit agreement that will fund a portion of the tender offer.
  • Spark Networks obtains chapter 15 recognition of first-ever cross-border restructuring under German StaRUGJones Day represented Spark Networks SE in the first-ever cross-border restructuring under the recently enacted German restructuring law ("StaRUG") and chapter 15 of the U.S. Bankruptcy Code involving over $100 million of funded debt issued by a U.S.-based credit fund and guaranteed by other German and U.S. entities.
  • Wabtec obtains $225 million term loan facilityJones Day represented Westinghouse Air Brake Technologies Corporation (“Wabtec”), a global provider of value-added, technology-based locomotives, equipment, systems and services for the freight rail and passenger transit industries, as well as the mining, marine, and industrial industries, in connection with its $225 million investment-grade term loan facility.
  • Wabtec completes $500 million public offering of Senior NotesJones Day represented Westinghouse Air Brake Technologies Corporation (“Wabtec”), a global provider of value-added, technology-based locomotives, equipment, systems and services for the freight rail and passenger transit industries, as well as the mining, marine, and industrial industries, in connection with its underwritten public offering of $500 million of 5.611% Senior Notes due 2034.
  • Omnicom Group completes €600 million public offering of Senior NotesJones Day represented Omnicom Group Inc., a leading global marketing and corporate communications company, in connection with the public offering by Omnicom Finance Holdings plc, its wholly-owned U.K. finance subsidiary, of €600 million of 3.700% Senior Notes due 2032.
  • The Stephens Group sells Summit Industrial Construction to Comfort Systems USAJones Day is advising The Stephens Group, LLC in the sale of portfolio company, Summit Industrial Construction, LLC, to Comfort Systems USA, Inc.
  • Cellectis and AstraZeneca enter into research collaboration and agree on equity investment of up to $220 million by AstraZenecaJones Day advised Cellectis in connection with the joint research collaboration agreement entered into with AstraZeneca and initial equity investment by AstraZeneca into Cellectis of $80 million.
  • Accelmed Partners leads $30 million private placement of Common Stock issued by Minerva Surgical, Inc.Jones Day represented Accelmed Partners in connection with its purchase of $30 million of Common Stock in a private placement issued by Minerva Surgical, Inc., granting Accelmed Partners a controlling stake in Minerva Surgical.
  • GreatPoint Ventures participates in $34 million investment in RapidDeployJones Day advised GreatPoint Ventures in connection with the $34 million investment in RapidDeploy, the leading provider of cloud-native 911 mapping and analytics solutions for Public Safety, led by Edison Partners.
    •

    Prima di procedere all'invio, si prega di notare:

    il contenuto del presente sito web è a scopo esclusivamente informativo e non può essere considerato un parere legale o altro tipo di consulenza professionale. L'invio o la ricezione della presente email non è atta ad instaurare alcun rapporto cliente/avvocato. Le informazioni inviate tramite questa funzione al nostro Studio non saranno coperte da vincolo di riservatezza o confidenzialità fintanto che non ci sia stato conferito e non sia stato da noi accettato un incarico professionale. Inviando il messaggio confermate di aver preso visione e accettato il contenuto di questa informativa.